Hirofumi Matsui

Prof. Hirofumi Matsui

Faculty of Medicine, University of Tsukuba, Ibaraki 305-0005, Japan
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
PDF file
Hirofumi MatsuiHirofumi Matsui
Hirofumi Matsui
OSOsamu Shimokawa
Osamu Shimokawa
TKTsuyoshi Kaneko
Tsuyoshi Kaneko
YNYumiko Nagano
Yumiko Nagano
KRKanho Rai
Kanho Rai
IHIchinosuke Hyodo
Ichinosuke Hyodo
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

1 October 2005 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
YNYumiko Nagano
Yumiko Nagano
Hirofumi MatsuiHirofumi Matsui
Hirofumi Matsui
MMMutsumi Muramatsu
Mutsumi Muramatsu
OSOsamu Shimokawa
Osamu Shimokawa
TSTakeshi Shibahara
Takeshi Shibahara
YNYukio Nakamura
Yukio Nakamura

1 January 2013 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
PDF file
MTMasato Tamura
Masato Tamura
Hirofumi MatsuiHirofumi Matsui
Hirofumi Matsui
TKTsuyoshi Kaneko
Tsuyoshi Kaneko
IHIchinosuke Hyodo
Ichinosuke Hyodo
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

7 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HKHiromi Kurokawa
Hiromi Kurokawa
HIHiromu Ito
Hiromu Ito
MTMasahiko Terasaki
Masahiko Terasaki
Hirofumi MatsuiHirofumi Matsui
Hirofumi Matsui
Photodynamic therapy (PDT) is a cancer treatment that make use of the cancer-specific accumulation of porphyrins. We have reported that mitochondrial reactive oxygen species (mitROS) upregulate uptake transporter of porphyrins, heme carrier protein-1 (HCP-1). The accumulation of cancer-specific porphyrins was increased by mitROS production, thereby the cancer-specific PDT cytotoxicity was enhanced. Thus we investigated whether mitROS production by hyperthermia can enhanced the cytotoxicity of PDT or not. In this study, 1 h of hyperthermia at 42 °C increased the mitROS production, and both the accumulation of cancer-specific porphyrins and the PDT cytotoxicity increased. Moreover, the authors treated cells with N-acetyl-L-cysteine (NAC) to examine the effect of mitROS. NAC inhibited the increasing ROS production after hyperthermia to restrain the post-treatment increase of cancer-specific porphyrins accumulation. Moreover, the increase of ROS production in cancer cells after hyperthermia upregulated HCP-1 expression and downregulated ABCG2 expression. These regulation were inhibited by NAC. These results suggest that hyperthermia treatment increased mitROS production, which involved HpD accumulation and enhanced PDT effects in cancer cells. The mechanism of this phenomenon was most likely to be due to both the upregulation of HCP-1 and the downregulation of ABCG2 by mitROS.

1 January 2014 in Journal of Clinical Biochemistry and Nutrition
Verified
Journal Article
Open access
PDF file
MTMasato Tamura
Masato Tamura
Hirofumi MatsuiHirofumi Matsui
Hirofumi Matsui
TTTsutomu Tomita
Tsutomu Tomita
HSHisato Sadakata
Hisato Sadakata
HIHiroko P. Indo
Hiroko P. Indo
IHIchinosuke Hyodo
Ichinosuke Hyodo
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

22 November 2007 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
OSOsamu Shimokawa
Osamu Shimokawa
Hirofumi MatsuiHirofumi Matsui
Hirofumi Matsui
YNYumiko Nagano
Yumiko Nagano
TKTsuyoshi Kaneko
Tsuyoshi Kaneko
TSTakeshi Shibahara
Takeshi Shibahara
YMYasushi Matsuzaki
Yasushi Matsuzaki